Svjetlana Gašparović Babić

Dr. Svjetlana Gašparović Babić

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2024 in Epidemiologia
Verified
Journal Article
Open access
PDF file
SBSvjetlana Gašparović Babić
Svjetlana Gašparović Babić
AKAntea Krsek
Antea Krsek
LBLara Baticic
Lara Baticic
Voluntary blood donation plays a crucial role in public health by ensuring a stable supply of blood and its components, essential for medical treatments including surgeries, trauma care, and chronic disease management. Voluntary donors, often healthier individuals, enhance the safety of the blood supply and play a vital role in emergency preparedness. Beyond its societal benefits, regular blood donation may offer health advantages for donors, including improved cardiovascular health due to reduced iron levels and psychological benefits stemming from altruism and a sense of social responsibility. Public health initiatives are instrumental in fostering blood donation through education, awareness campaigns, and targeted donor recruitment strategies. These efforts encourage a culture of social responsibility, inspiring community participation and improving overall healthcare system sustainability. Despite these efforts, challenges such as fluctuating donation rates, aging populations, and shifting demographics underscore the need for ongoing initiatives to ensure a sufficient blood supply. As a public health priority, voluntary blood donation demands continuous promotion and innovation to meet the growing demand for blood products and maintain healthcare system resilience. This review highlights the public health significance of voluntary blood donation, with particular focus on its benefits for donors and its role in supporting healthcare systems.

5 September 2018 in BMJ Open
Verified
Journal Article
Open access
PDF file
MHMichael Harris
Michael Harris
PVPeter Vedsted
Peter Vedsted
MEMagdalena Esteva
Magdalena Esteva
PMPeter Murchie
Peter Murchie
IAIsabelle Aubin-Auger
Isabelle Aubin-Auger
GTGordon Taylor
Gordon Taylor
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe. These differences may be partly due to variations in access to investigations and specialists. However, evidence to explain how different national health systems influence primary care practitioners’ (PCPs’) referral decisions is lacking. This study analyses health system factors potentially influencing PCPs’ referral decision-making when consulting with patients who may have cancer, and how these vary between European countries. Design Based on a content-validity consensus, a list of 45 items relating to a PCP’s decisions to refer patients with potential cancer symptoms for further investigation was reduced to 20 items. An online questionnaire with the 20 items was answered by PCPs on a five-point Likert scale, indicating how much each item affected their own decision-making in patients that could have cancer. An exploratory factor analysis identified the factors underlying PCPs’ referral decision-making. Setting A primary care study; 25 participating centres in 20 European countries. Participants 1830 PCPs completed the survey. The median response rate for participating centres was 20.7%. Outcome measures The factors derived from items related to PCPs’ referral decision-making. Mean factor scores were produced for each country, allowing comparisons. Results Factor analysis identified five underlying factors: PCPs’ ability to refer; degree of direct patient access to secondary care; PCPs’ perceptions of being under pressure; expectations of PCPs’ role; and extent to which PCPs believe that quality comes before cost in their health systems. These accounted for 47.4% of the observed variance between individual responses. Conclusions Five healthcare system factors influencing PCPs’ referral decision-making in 20 European countries were identified. The factors varied considerably between European countries. Knowledge of these factors could assist development of health service policies to produce better cancer outcomes, and inform future research to compare national cancer diagnostic pathways and outcomes.

2 January 2017 in Scandinavian Journal of Primary Health Care
Verified
Journal Article
Open access
MHMichael Harris
Michael Harris
PFPeter Frey
Peter Frey
MEMagdalena Esteva
Magdalena Esteva
SBSvjetlana Gašparović Babić
Svjetlana Gašparović Babić
MMMercè Marzo-Castillejo
Mercè Marzo-Castillejo
HTHans Thulesius
Hans Thulesius
Objective: European cancer survival rates vary widely. System factors, including whether or not primary care physicians (PCPs) are gatekeepers, may account for some of these differences. This study explores where patients who may have cancer are likely to present for medical care in different European countries, and how probability of presentation to a primary care clinician correlates with cancer survival rates. Design: Seventy-eight PCPs in a range of European countries assessed four vignettes representing patients who might have cancer, and consensus groups agreed how likely those patients were to present to different clinicians in their own countries. These data were compared with national cancer survival rates. Setting: A total of 14 countries. Subjects: Consensus groups of PCPs. Main outcome measures: Probability of initial presentation to a PCP for four clinical vignettes. Results: There was no significant correlation between overall national 1-year relative cancer survival rates and the probability of initial presentation to a PCP (r = −0.16, 95% CI −0.39 to 0.08). Within that there was large variation depending on the type of cancer, with a significantly poorer lung cancer survival in countries where patients were more likely to initially consult a PCP (lung r = −0.57, 95% CI −0.83 to −0.12; ovary: r = −0.13, 95% CI −0.57 to 0.38; breast r = 0.14, 95% CI −0.36 to 0.58; bowel: r = 0.20, 95% CI −0.31 to 0.62). Conclusions: There were wide variations in the degree of gatekeeping between countries, with no simple binary model as to whether or not a country has a “PCP-as-gatekeeper” system. While there was case-by-case variation, there was no overall evidence of a link between a higher probability of initial consultation with a PCP and poorer cancer survival.

1 June 2015
Verified
Journal Article
Closed access
ITIva Sorta-Bilajac Turina
Iva Sorta-Bilajac Turina
HKHelena Glibotić Kresina
Helena Glibotić Kresina
SBSvjetlana Gašparović Babić
Svjetlana Gašparović Babić
SJSuzana Janković
Suzana Janković
SKSandro Kresina
Sandro Kresina
MBMorana Brkljačić
Morana Brkljačić

1 September 2023 in Medicina Fluminensis
Verified
Journal Article
Open access
PDF file
SMSilvia Mohorić
Silvia Mohorić
IAIvan Anić
Ivan Anić
SBSvjetlana Gašparović Babić
Svjetlana Gašparović Babić
HKHelena Glibotić Kresina
Helena Glibotić Kresina
ITIva Sorta-Bilajac Turina
Iva Sorta-Bilajac Turina
Svjetska zdravstvena organizacija, posebno koordinirajuće tijelo međunarodnog javnog zdravstva Ujedinjenih naroda, ima izniman značaj u razvoju i unaprjeđenju javnog zdravstva na globalnoj razini te ove godine slavi 75 godina svog postojanja. Jedan o...

17 April 2024 in Lijecnicki Vjesnik
Verified
Journal Article
Open access
PDF file
SBSvjetlana Gašparović Babić
Svjetlana Gašparović Babić
ITIva Sorta-Bilajac Turina
Iva Sorta-Bilajac Turina
SMSilvia Mohorić
Silvia Mohorić
HKHelena Glibotić Kresina
Helena Glibotić Kresina